Document is current
Any future updates will be listed below
-
Authors
Sui, Zhilin
Wu, Xianxian
Wang, Jiaxin
Tan, ShihJye
Zhao, Chao
Yu, Zhentao
Wu, Chuanyue
Wang, Xiaoxiao
Guo, Ling https://orcid.org/0000-0003-1118-6798
-
Funding
Funding for this research was provided by:
Key Technologies Research and Development Program of Guangzhou Municipality (2019YFA0906000)
Innovative Research Group Project of the National Natural Science Foundation of China (82273308)
Basic and Applied Basic Research Foundation of Guangdong Province (2021A1515111132)
Shenzhen Medical Research Fund (D2301001, B2402032)
Shenzhen Science and Technology Innovation Program (JHZ20220913142804008, JCYJ20220530112817040)
Shenzhen Science and Technology Program (ZDSYS20220606101604009)
Shenzhen Key Medical Discipline Construction Fund (SZXK075)
Sanming Project of Medicine in Shenzen Municipality (SZSM202211011)
- License Information
-
More Information
Article History
Received: 26 August 2024
Accepted: 21 December 2024
First Online: 9 January 2025
Declarations
:
: All procedures were approved by the Ethics Committee of Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences. The research project titled “Construction of mechanistic tumor organoid based on ECM-mediated proline metabolism” was approved on November 15, 2023 (No. KYKT2023-22-1). Patients or their guardian(s)/legally authorized representative(s) provided written informed consent for their participation in the study and the use of their tissue.
: Not applicable.
: The authors report no conflicts of interest in this work.
